Manufacturers Life Insurance Company, The Viridian Therapeutics, Inc.\De Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 49,720 shares of VRDN stock, worth $758,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,720
Previous 24,732
101.04%
Holding current value
$758,727
Previous $562,000
69.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VRDN
# of Institutions
200Shares Held
79.4MCall Options Held
477KPut Options Held
917K-
Black Rock Inc. New York, NY4.77MShares$72.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$70.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.52MShares$69 Million3.82% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$59.3 Million12.28% of portfolio
-
State Street Corp Boston, MA3.52MShares$53.8 Million0.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $609M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...